Menu

First Documented Case of Transgender Mother Breastfeeding

Doctors report that a regimen of hormones, an antiemetic drug, and pumping gave the woman enough milk production to feed her baby exclusively breastmilk for six weeks.

Feb 15, 2018
Kerry Grens

ISTOCK, SWEETLEMONTEATwo New York physicians report that, for the first time, a transgender woman has been able to breastfeed her child, and did so for six weeks.

The 30-year-old patient of theirs took hormones and an anti-nausea medication for three months, after which she was producing eight ounces of milk per day, the doctors reported in Transgender Health this January. Two weeks later, her partner gave birth and the baby’s growth and development progressed well during six weeks of exclusive breastfeeding from the transgender mom, after which the parents began supplementing with formula.

“There have been self-reported cases online of transgender women trying DIY regiments to induce breastfeeding, but this is the first case of induced functional lactation in the academic literature,” one of the doctors, Tamar Reisman of Mount Sinai hospital, tells The Guardian.

Boston Medical Center’s Joshua Safer, who did not treat the mom, tells New Scientist that transgender women tend to have “good breast development,” and that it’s not surprising this individual would be able to produce milk with the tissue. “This is very special. It will be very important for the many transgender women who want to breastfeed but do not feel they have the opportunity to do so.”

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.